Although clinical trials using matrix metalloproteinase inhibitors (MMPIs) for cancer therapy were disappointing, Opdenakker and colleagues discuss how the use of selective MMPIs might lead to new ...

Days ago, for the first time since I started with Catalyst2 in 2004, the invoices of Catalyst2 officially came through as ...